Study of the Articular Microbiota in Rheumatoid Arthritis.
NCT04056234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2019-08-14
Summary
The cause of rheumatoid arthritis (RA) remains unknown, although major advances have been done these last ten years in the comprehension of its pathophysiology.
The aim of this study is to described a synovial microbiota specific for rheumatoid arthritis.
Conditions
- Rheumatoid Arthritis
- Synovial Disorder
- Arthrosis
Interventions
- PROCEDURE
-
Joint puncture
Patient requiring joint puncture for diagnostic or therapeutic reasons.
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Emilie SHIPLEY, Dr · University Hospital, Bordeaux
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-21
- Primary Completion
- 2013-02-22
- Completion
- 2013-02-22
More Related Trials
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
NCT01443364 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis
NCT01765374 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis
NCT04853212 ·Status: RECRUITING ·Phase: NA
-
A Rheumatoid Arthritis Study in Participants
NCT01202760 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Rheumatoid Arthritis
NCT01253265 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy
NCT04281602 ·Status: UNKNOWN
-
Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis
NCT02765074 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)
NCT00753454 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
NCT01213017 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis
NCT00424294 ·Status: TERMINATED ·Phase: PHASE2
-
A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).
NCT01734993 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
Faecal Analyses in Spondyloarthritis Therapy
NCT03839862 ·Status: RECRUITING
-
Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis
NCT00554606 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy
NCT00785928 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Extension Study in Participants With Rheumatoid Arthritis
NCT00837811 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
NCT00034203 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment
NCT05654753 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
NCT00689728 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis
NCT03416543 ·Status: COMPLETED
-
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
NCT01198509 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Treatment of Rheumatoid Arthritis
NCT03690466 ·Status: COMPLETED ·Phase: NA